Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
We utilise our cutting-edge, exclusive workflow to develop focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q5ST30
UPID:
SYVM_HUMAN
Alternative names:
Valyl-tRNA synthetase; Valyl-tRNA synthetase-like
Alternative UPACC:
Q5ST30; A2ABL7; B4DET4; B4E3P5; F5GXJ0; F5H323; Q2M2A0; Q59FI1; Q5SQ96; Q5SS98; Q6DKJ5; Q6ZV24; Q96GN2; Q96H77; Q96Q02; Q9H6R2; Q9UFH7
Background:
Valine--tRNA ligase, mitochondrial, also known as Valyl-tRNA synthetase, plays a crucial role in protein synthesis by attaching valine to its corresponding tRNA. This enzyme is essential for mitochondrial function and energy production.
Therapeutic significance:
Linked to Combined oxidative phosphorylation deficiency 20, a disorder characterized by muscle weakness, neurological disease, and cardiomyopathy, understanding Valine--tRNA ligase's role could unveil new therapeutic strategies.